Imaging of Salivary Gland Tumors and Their Relevance

Review available imaging studies for diagnosis of salivary gland tumors, including ultrasound, CT and MRI, with Kevin J. Abrams, M.D. 

Target Audience

Primary Care Physicians, Dentists, Otolaryngologists, Gastroenterologists, Radiologists, Medical Oncologists, Oral Maxillofacial Surgeons, Surgeons, Pathologists, Hospitalists, Physician Assistants. 

Learning Objectives

  • Assess and review the best imaging strategies in patients with suspected salivary gland tumors. 
  • Identify the limitations of CT and MRI in evaluating salivary gland tumors. 
Additional information
Bibliography: 

Razek, A. A. K. A., & Mukherji, S. K. (2018). State-of-the-art imaging of salivary gland tumors. Neuroimaging Clinics of North America, 28(2), 303-317.

Course Summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 General certificate of attendance
Course opens: 
05/01/2019
Course expires: 
04/30/2022

Kevin J. Abrams, M.D.
Chief of Radiology 
Medical Director, Neuroradiology
Baptist Hospital 
Clinical Associate Professor of Radiology
Herbert Wertheim College of Medicine, Florida International University
Miami, Florida

Kevin J. Abrams, M.D., faculty for this educational activity, is a consultant, member of the speakers' bureau and a stockholder with Keystone Homart and has indicated that the presentation or discussion will not include off-label or unapproved product usage. 

Conference Directors
Guilherme Rabinowits, M.D., has indicated that he is a consultant for Pfizer, Merck, Sanofi, Castel, Lighthouse, EMD Serono and Regeneron and a stockholder with Regeneron and Syros Pharmaceuticals.

Geoffrey Young, M.D., has no relevant financial relationship with ineligible companies* to disclose. 

All of the relevant financial relationships listed for these individuals have been mitigated.

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.  

*Ineligible companies -- Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
              
Baptist Health South Florida designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 General certificate of attendance
Please login or register for a Baptist Health CME account to take this course.

Required Hardware/Software

PC/Mac Users
PC/Mac Users

This site is supported on the most recent stable releases of the following browsers:

Click Here to Download Google Chrome
Google Chrome		Microsoft Edge
Microsoft Edge		Safari
Safari		Moxilla Firefox
Mozilla Firefox
Internet Explorer

Attention: Internet Explorer Users
This site offers limited support for Internet Explorer 11 (IE11). When using IE11, you will be prompted to download course videos instead of viewing them in the browser. After the course video downloads, the recordings will play.

Mobile Users
Mobile Users

This site is supported on the following mobile devices:

  • Apple iOS mobile devices running iOS 10 or later
  • Android mobile devices running Android 4.4 or later, with the latest release of Google Chrome or Mozilla Firefox
Technical Support
Technical Support

If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.